SCHEMBL25916502

SCHEMBL25916502

Cc1ccc(C(=O)Nc2ccc(C)cc2-c2nc3ccccc3s2)cc1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 14/20 0.61
RXFP1 Q9HBX9 5/20 0.61
NPSR1 Q6W5P4 2/20 0.59
MEN1 O00255 1/20 0.59
CYP3A4 P08684 1/20 0.59
CYP2C9 P11712 1/20 0.59
KMT2A Q03164 1/20 0.59
HPGD P15428 1/20 0.59
TP53 P04637 4/20 0.59
ALDH1A1 P00352 1/20 0.58
LMNA P02545 1/20 0.55
USP2 O75604 1/20 0.55
TSHR P16473 1/20 0.55
MAPK1 P28482 1/20 0.55
ATM Q13315 1/20 0.55
HSD17B10 Q99714 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
SMN1; SMN2 Q16637 2/20 0.53
SCD O00767 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25916306 0.95 HPGD (0.62) MAPTRXFP1NPSR1MEN1CYP3A4
SCHEMBL30362642 0.95 HPGD (0.62) MAPTRXFP1NPSR1MEN1CYP3A4
SCHEMBL25916475 0.93 MAPT (0.70) MAPTRXFP1NPSR1MEN1CYP3A4
SCHEMBL30211749 0.92 MAPT (0.55) MAPTRXFP1NPSR1MEN1CYP3A4
SCHEMBL25916307 0.92 MAPT (0.55) MAPTRXFP1NPSR1MEN1CYP3A4
SCHEMBL25916557 0.91 MAPT (0.57) MAPTRXFP1NPSR1MEN1CYP3A4
SCHEMBL25916534 0.91 MAPT (0.57) MAPTRXFP1NPSR1MEN1CYP3A4
SCHEMBL25916518 0.89 MAPT (0.70) MAPTRXFP1NPSR1MEN1CYP3A4
SCHEMBL25916842 0.87 MAPT (0.66) MAPTRXFP1NPSR1MEN1CYP3A4
SCHEMBL25916389 0.85 MAPT (0.53) MAPTRXFP1NPSR1HPGDTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230235190-A1 FLUORESCENT COMPOSITION COMPRISING AT LEAST ONE BENZAZOLE COMPOUND FOR THE SECUREMENT OF PRODUCTS Crime Science Technology (FR) 2023-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230235190-A1 FLUORESCENT COMPOSITION COMPRISING AT LEAST ONE BENZAZOLE COMPOUND FOR THE SECUREMENT OF PRODUCTS TUBB3, TUBA3C, PHB1 MAPT 318/4885RXFP1 1340/4885NPSR1 4524/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.